BIOCOM for BIOCOM
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Aug 6, 2012 | $52,000 | Replaced |
| 2nd Quarter - Report (this page) | Aug 6, 2012 | $52,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-Voiced support for the FDA User Fee Reauthorization -Voiced Support for the "Breakthroughs" provision included in the FDA User Fee Reauthorization -Voiced support for de novo process changes in the user fee package -Voiced support for GAIN within the FDA user fee package
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Energy/Nuclear ENG
Voiced Support for the Energy title programs within the 2002 farm bills to be included in the new Farm Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Taxation/Internal Revenue Code TAX
- Voiced support for Medical Device Excise Tax Repeal Efforts, HR 463 - Voiced support for HR4953, the Qualifying renewable chemical production tax credit Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE BAUDOIN | — |
| JOE PANETTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.